๐ฐ Leukemia News
Page 115 - Leukemia News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Leukemia. Real-time updates on events, politics, business and more.
June 8, 2023
First-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic lymphocytic leukemia (CLL) whether or not their cancer harbored high-risk genetic features typically associated with poor outcomes, according to results published in Clinical Cancer Research, a journal of the American Association for Cancer Research (AACR).
June 8, 2023
The study sheds light on how other cancers originate, particularly those involving blood or lymph cells that move via the circulation to all parts of the body.
June 8, 2023
You can sign up for a fitness charity class that honors the memory of a North Tonawanda High School graduate.
June 7, 2023
The new study uncovers the efficacy of fixed-duration combination treatment in patients with high-risk leukemia.
June 7, 2023
All cancers survivors, regardless of therapy, should be regularly screened for new-onset neurocognitive problems "decades" after diagnosis, researchers say.
June 6, 2023
Lasting guilt gets no one anywhere โ especially when it comes to cancer.
June 6, 2023
Friends and family of a young Lexington boy battling cancer came together for a very special surprise that might make you a little teary-eyed.
June 5, 2023
At the 2023 American Society for Clinical Oncology Annual Meetingโto be held June 2-6 in Chicago, IllinoisโFred Hutchinson Cancer Center experts will present research spanning survivorship, advances in treatments and clinical trials, how access to cancer care affects outcomes, integrative medicine and more.
June 5, 2023
Acute myeloid leukemia (AML) is a very aggressive disease in which cells proliferate abnormally, invading the bone marrow and interfering with normal blood cell production. It is the most common acute leukemia in adults with the worst prognosis.
June 5, 2023
Newly published data indicates that widely available medications for chronic lymphocytic leukemia (CLL) have steadily improved overall survival rates over most of the past three decades.